Definitive Contract 75F40120C00191
Award Date
9/27/20
Potential Completion Date
12/31/23
Potential Value
$518K
Federal Agency
Food and Drug Administration
Awardee
Alliance Nctn Foundation
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Chicago, IL 60606, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,275,361.26 definitive cost-no-fee contract to Alliance Nctn Foundation, a non-profit organization and foundation, to conduct the "Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Data Capture and Standardization Study". This contract, with a performance period ending on September 29, 2024, is part of the FDA's broader efforts to advance regulatory science and support public...
This is a definitive $138,204.70 cost-no-fee contract awarded by the Food and Drug Administration (FDA) to the Alliance Nctn Foundation, a non-profit organization and foundation. The contract is for the real-world collection of radiographic images and treatment emergent adverse event data to support the next phase of development of the ICAREDATA research institute. This contract does not have a set-aside designation. Through this work, the Alliance Nctn Foundation serves as a prime contractor...
The Department of Health and Human Services Food and Drug Administration awarded a $350,000 definitive cost-no-fee contract to Elligo Health Research, Inc. to support the agency's Broad Agency Announcement seeking proposals to extend the value of common data model harmonization in generating clinical evidence from real world data sufficient to support regulatory use. The small disadvantaged business will perform work at locations in Silver Spring, Maryland under the contract addressing the FDA's...
The U.S. Food and Drug Administration (FDA), an agency of the Department of Health and Human Services (HHS), awarded International Consulting Associates Inc. (ICA) a firm fixed price purchase order valued at approximately $596,416 to conduct an endovascular aneurysm repair endovascular graft study using real-world data. ICA will perform the study as the prime contractor. The FDA requires this study to support its regulatory responsibilities. The contract has a period of performance from April 5,...
The U.S. Food and Drug Administration (FDA) has awarded a $4,077,696.00 Firm Fixed Price, Definitive Contract to International Consulting Associates, Inc. (ICA) to develop AI-enabled user workflows and dashboards for the Center for Devices and Radiological Health (CDRH). This 8(a) sole source contract, running through September 2024, is part of the FDA's broader "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative. ICA, an...
The Department of Health and Human Services Food and Drug Administration awarded a $219,885.00 purchase order contract to Healthpartners Institute, a non-profit organization, to conduct a study on the association between oral transmucosal pain reduction drugs and dental adverse events using integrated real-world data sources. The contract has a completion date of December 31, 2023 and is a labor hours-based contract. No set-aside designation was used for this award. Healthpartners Institute is a...
This is a $4,456,062.35 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for support to conduct 10 post-market safety studies, with a period of performance through August 29, 2025. ICA has an extensive track record of delivering a wide range of healthcare IT, data analytics, and management consulting services to federal...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order contract to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small disadvantaged business, to provide contractor support in identifying regulatory submissions supported by real-world evidence (RWE). The $153,980.77 contract aims to leverage ICA's expertise in healthcare data analytics, artificial intelligence, medical device safety, and RWE...
The Food and Drug Administration (FDA) awarded a $3,821,128.80 firm-fixed-price contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. This contract is part of the FDA's Center for Devices and Radiological Health's (CDRH) Medical Data Enterprise Initiative, which aims to streamline the use of real-world data and integrate it with CDRH data. ICA will provide advanced data analytics, artificial intelligence, healthcare...